These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 4623975

  • 1. Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses?
    Neu C, Dimascio A, Demirgian E.
    Curr Ther Res Clin Exp; 1972 May; 14(5):246-51. PubMed ID: 4623975
    [No Abstract] [Full Text] [Related]

  • 2. Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics.
    Klett CJ, Caffey E.
    Arch Gen Psychiatry; 1972 Apr; 26(4):374-9. PubMed ID: 4552131
    [No Abstract] [Full Text] [Related]

  • 3. A quantitative study of neuroleptic-induced extrapyramidal symptoms and their response to dexetimide, a potent and long-acting antiparkinsonian agent.
    Dom R, Van Lommel R, Baro F.
    Acta Psychiatr Scand; 1971 Apr; 47(4):399-410. PubMed ID: 4947805
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Reversal of some therapeutic effects of an antipsychotic agent by an antiparkinsonism drug.
    Singh MM, Smith JM.
    J Nerv Ment Dis; 1973 Jul; 157(1):50-8. PubMed ID: 4713306
    [No Abstract] [Full Text] [Related]

  • 6. [A new synthetic antiparkinsonian drug, tropatepine hydrochloride in extrapyramidal syndromes induced by neuroleptics].
    Lambert A, dachary JM, Marie C, Oules J, Pagot R, Sales M, Vauterin C.
    Encephale; 1976 Jul; 2(2):115-21. PubMed ID: 776591
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Some methodological considerations in the evaluation of drug-induced extrapyramidal disorders: a study of Ex10-029, a new morphanthridine derivative.
    Simpson GM, Beckles D, Isalski Z, Lee JH.
    J Clin Pharmacol New Drugs; 1972 Apr; 12(4):142-52. PubMed ID: 4553448
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action.
    Huygens H, Vereecken JL, Tanghe A.
    Psychiatr Neurol Neurochir; 1973 Apr; 76(4):251-9. PubMed ID: 4581374
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Study of the effect of certain pharmacological agents on tardive dyskinesias and the rabbit syndrome].
    Jus K, Jus A, Gautier J, Villeneuve A, Pires P, Pineau R, Villeneuve R.
    Vie Med Can Fr; 1973 Sep; 2(9):871-5. PubMed ID: 4761483
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Clinical study of a new agent correcting the syndrome of neuroleptic impregnation in acute psychotic states].
    Vauterin C, Veillon F.
    Encephale; 1975 Sep; 1(1):61-8. PubMed ID: 1093847
    [Abstract] [Full Text] [Related]

  • 15. Management of extrapyramidal side effects induced by neuroleptics.
    Tune LE, McHugh PR, Coyle JT.
    Johns Hopkins Med J; 1981 Mar; 148(3):149-53. PubMed ID: 7206408
    [No Abstract] [Full Text] [Related]

  • 16. Loxapine: a six-month evaluation in severely ill schizophrenic patients.
    Gallant DM, Bishop G, Steel CA, Bishop MP.
    Curr Ther Res Clin Exp; 1973 Apr; 15(4):205-9. PubMed ID: 4633281
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Extra-pyramidal syndrome caused by neuroleptics].
    Lambert PA.
    Encephale; 1973 Apr; 62(1):78-105. PubMed ID: 4718697
    [No Abstract] [Full Text] [Related]

  • 19. Studies on the action of certain pharmacological agents on tardive dyskinesia and on the rabbit syndrome.
    Jus K, Jus A, Gautier J, Villeneuve A, Pires P, Pineau R, Villeneuv R.
    Int J Clin Pharmacol; 1974 Mar; 9(2):138-45. PubMed ID: 4827556
    [No Abstract] [Full Text] [Related]

  • 20. [Study of the delayed-action form of a synthetic antiparkinsonian drug: Akineton].
    Kammerer T, Schweitzer-Bucher E, Jamet P, Royer M.
    Ann Med Psychol (Paris); 1972 May; 1(5):688-96. PubMed ID: 5081112
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.